Patents

Garreth’s experience in the patent profession, both in private practice and as an in-house attorney in Pfizer’s European patent department, have focused strongly on pharmaceutical patents.

Garreth’s technical expertise covers all types of chemical subject matter including food chemistry, petrochemicals, agricultural chemistry, polymer chemistry and chemical syntheses and processes. In the pharmaceuticals sector, Garreth handles patent applications for new active substances, formulations, combination therapies, new medical indications, and manufacturing processes.

He has particular expertise in obtaining supplementary protection certificates (SPCs) and other forms of patent term extension, advising clients on SPC strategies and filing and prosecuting SPC portfolios throughout Europe on a number of important marketed pharmaceutical and plant protection products.

Prior to joining D Young & Co in 2007 Garreth worked both in private practice and in Pfizer’s European patent department. Garreth’s responsibilities at Pfizer included drafting and prosecuting pharmaceutical patent applications worldwide, providing validity and freedom-to-operate opinions and advising on a range of intellectual property matters. His experience there included a secondment to the Pfizer site in Ann Arbor, US.

European patent attorney 2002; chartered patent attorney 2005; chartered chemist; partner at D Young & Co 2011.

Chartered Institute of Patent Attorneys (CIPA); European Patent Institute (epi); Royal Society of Chemistry (RSC).

St Anne’s College, University of Cambridge (MChem in Chemistry); Research project on free-radical routes to novel alkaloids; Queen Mary College, University of London (Certificate in Intellectual Property Law).